Ferring

Ferring, Adstiladrin, Gene therapy, bladder cancer, FDA, early experience program

Ferring launches bladder cancer gene therapy Adstiladrin in US through early experience program

Anika Sharma

Ferring Pharmaceuticals achieved a significant milestone by administering its groundbreaking gene therapy, Adstiladrin, to its first commercial patient. This innovative ...